Skip to main content

Asymchem Laboratories (Tianjin) Co., Ltd. (002821.SZ)

50.5Fair

ValueMarkers Composite Index

Top 31%#30,961 of 44,714

DCF data not available

Piotroski
4/9
Neutral
Beneish
-2.49
Low Risk
Altman
9.88
Safe
DCF Value
-
N/A
ROIC
7.6%
Low
P/E
38.4
Growth
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Asymchem Laboratories (Tianjin) Co., Ltd. (002821.SZ) — VMCI valuation read

002821.SZ screens at VMCI 51/100, a 1-point gap above the Healthcare sector median (50). For a mid-cap Asymchem Laboratories (Tianjin) Co., Ltd. share, that placement says the multi-pillar composite is cheaper or higher quality than the typical peer on a like-for-like basis.

002821.SZ has logged no Form 4 insider activity over the trailing 30 days. The tape reads neither bullish nor bearish on insider conviction. The next signal sits with the 10-Q schedule and the analyst calendar.

**Investor frame.** Value: 002821.SZ trades at 20.0x earnings, 11% above the Healthcare median of 18.0x, while EV/EBITDA prints 9.0x against 12.0x for the Healthcare group. Quality: ROIC of 16.0% sits 6.0pp above the Healthcare median (10.0%), the cleanest like-for-like comparison on capital efficiency. Risk: net debt to EBITDA of -0.1x leaves covenant headroom, which sets the rate-cycle exposure for Asymchem Laboratories (Tianjin) Co., Ltd..

002821.SZ fell 2.0% over the trailing 7 days, with a -9.6% read on a 30-day basis.

Asymchem Laboratories (Tianjin) Co., Ltd. provides contract development and manufacturing organization services in Mainland China and internationally. The company offers drug research and development, and manufacturing services for pharmaceutical and biotech companies. Its solutions range from early clinical stage to commercial stage, including research and development, and cGMP production of advanced intermediates, active pharmaceutical ingredients, and formulations, as well as clinical research services. The company also engages in the provision of pharmaceutical analysis and testing services; sale, wholesale, and retail of drugs; and pharmaceutical science and technology development activities. The company was founded in 1999 and is headquartered in Tianjin, China.

CEO: Hao Hong9,595 employeesCNwww.asymchem.com.cn

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in 002821.SZ’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.